BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• 

  Drug Development

  Allergan CEO Committed to Company’s Business Strategy Despite Concerns of Some Investors

  Allergan Chief Executive Officer Brent Saunders delivered a rosy review of the first quarter for 2018, including a 3 percent growth in revenue to $3.67 billion over the past three months. However, investors are not terribly pleased and shares have fallen nearly 4 percent this morning.

  April 30, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Are All Cancers Rare Cancers?

  Biopharmaceutical companies are focusing their drugs for smaller and smaller and more clearly delineated patient populations. No longer is a drug for lung cancer or even non-small cell lung cancer, but a much smaller segment.

  April 30, 2018

   · 

  4 min read

   · 

  Mark Terry
• Belgian Microbiome Spin-off A-Mansia Announces €13m First Close of Series A Financing

  A-Mansia Biotech S.A. announces a €13 million first close of its Series A financing, led by Seventure Partners. The financing round remains open for additional investment.

  April 30, 2018

   · 

  4 min read
• Business

  Lord Prior to Serve as a Senior Adviser to Lazard Financial Advisory

  Lazard Ltd announced that Lord David Prior, the former Under Secretary of State to the Department for Business, Energy and Industrial Strategy (BEIS) and Minister for NHS Productivity at the Department of Health, will serve as a Senior Adviser to Lazard, Financial Advisory, effective immediately.

  April 30, 2018

   · 

  2 min read
• Business

  Make-A-Wish® Sets Guinness World Records™ Title

  Make-A-Wish® - the global organization that creates life-changing wishes for children with critical illnesses - is thrilled to announce a Guinness World Record title achievement of being named the Largest wish-granting non-profit organization.

  April 30, 2018

   · 

  3 min read
• Number of Shares and Votes in Medivir Changed As A Result of Conversion

  Medivir AB announces that the number of shares and votes in Medivir has changed as a result of conversion of all class A shares to class B shares.

  April 30, 2018

   · 

  1 min read
• Business

  Glythera Appoints Professor Kerry Chester to SAB

  Glythera Limited announces that it has appointed Professor Kerry Chester to its Scientific Advisory Board (SAB).

  April 30, 2018

   · 

  1 min read
• Deals

  Centene Corporation Announces Offering of Common Stock at $0.001 per Share

  Centene Corporation announced that it has commenced an offering to sell $2.6 billion in shares of common stock, par value $0.001 per share.

  April 30, 2018

   · 

  4 min read
• Bio NC

  Aerie Pharmaceuticals Announces U.S. Launch of Rhopressa® (netarsudil ophthalmic solution) 0.02%

  Aerie Pharmaceuticals, Inc. announced that it has launched Rhopressa® in the United States.

  April 30, 2018

   · 

  6 min read
• FDA

  FDA Grants Priority Review to Merck’s sBLA for KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed (ALIMTA®) and Platinum Chemotherapy Based on Results from Phase 3 KEYNOTE-189 Trial as First-Line Treatment of Metastatic Nonsquamous NSCLC

  Merck announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for KEYTRUDA.

  April 30, 2018

   · 

  24 min read